U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX24584867: GSM8273564: E. coli strain A, control strain, rep 1; Escherichia coli str. K-12 substr. MG1655; RNA-Seq
1 DNBSEQ (DNBSEQ-G400) run: 23.4M spots, 4.7G bases, 2.7Gb downloads

External Id: GSM8273564_r1
Submitted by: Tianjin University
Study: Genome-scale CRISPRi screen identifies pcnB repression conferring improved physiology for overproduction of free fatty acids in Escherichia coli
show Abstracthide Abstract
Microbial physiology plays a pivotal role in construction of a superior microbial cell factory for efficient production of desired products. Here we identified pcnB repression through genome-scale CRISPRi modulation combining fluorescence-activated cell sorting (FACS) and next-generation sequencing (NGS), which confers improved physiology for free fatty acids (FFAs) overproduction in Escherichia coli. The repression of pcnB could improve the stability and abundance of the transcripts involved in proton-consuming system, conferring a global improvement on cell membrane, redox state, and energy level. These physiological advantages facilitated further identification of acrD repression enhancing FFAs efflux. The engineered strain pcnBi-acrDi-fadR+ achieved 35.1?g?l-1 FFAs production in fed-batch fermentation, which is the maximum titer in E. coli reported to date. This study underscores the significance of hidden genetic determinants in microbial biosynthesis and sheds light on the role of microbial physiologies in boosting microbial biosynthesis. Overall design: In this study, we carried out genome-scale CRISPRi modulation combining fluorescence-activated cell sorting (FACS) and next-generation sequencing (NGS) to identify genetic determinants for FFAs overproduction in Escherichia coli. The pcnBi (AP) strain that repressed the expression of pcnB produced 2992 mg l FFAs, which was 4.0-fold of the CF (A) strain. To analyze the underlying mechanism of FFAs overproduction, the engineered strain pcnBi and the control strain CF were applied to the transcriptomic and proteomic analyses.
Sample: E. coli strain A, control strain, rep 1
SAMN41426576 • SRS21324619 • All experiments • All runs
Library:
Name: GSM8273564
Instrument: DNBSEQ-G400
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Total RNA was extracted using the RiboPure™ Bacteria Kit (Invitrogen, USA) following the manufacturer's recommendations. RNA quality was checked using the DNF-471 Standard Sensitivity RNA Analysis Kit (Agilent, USA) and running on Fragment Analyzer (Agilent, USA). RNA sample was treated with DNase-I to remove DNA and was subjected to TIANSeq rRNA Depletion Kit (G- Bacteria) (TIANGEN, China) to remove rRNA. Sequencing libraries were constructed using the Optimal Dual-mode mRNA Library Prep Kit (BGI, China) following the manufacturer's instructions. Circularization was performed using the MGIEasy Circularization Kit (MGI, China) and the product was quantitated using the Qubit® ssDNA Assay Kit (Invitrogen, USA). The libraries were then prepared using the MGISEQ-2000RS High-throughput Sequencing Set (FCL PE100) (MGI, China) and sequenced via the DNBSEQ-G400 platform (BGI, China) according to the manufacturer's instructions.
Runs: 1 run, 23.4M spots, 4.7G bases, 2.7Gb
Run# of Spots# of BasesSizePublished
SRR2906010023,377,9114.7G2.7Gb2024-05-21

ID:
32903124

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...